Advanced Stage Is the Most Important Prognostic Factor for Survival in Patients with Systemic Acquired Immunodeficiency Syndrome-Related Non-Hodgkin’s Lymphoma Treated with CHOP and Highly Active Antiretroviral Therapy

No abstract is available for this paper.

• Publication year

  2007

• Venue

  International journal of hematology

• Publication date

  2007-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1532/IJH97.E0636PMID 18055341
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• AIDS-related malignancies: changing epidemiology and the impact of highly active antiretroviral therapy

  2006cited by this paper
• AIDS-related lymphoproliferative disease.

  2006cited by this paper
• The prognosis of HIV-infected patients with diffuse large B-cell lymphoma treated with chemotherapy and highly active antiretroviral therapy is similar to that of HIV-negative patients receiving chemotherapy.

  2005cited by this paper
• Rituximab plus infusional cyclophosphamide, doxorubicin, and etoposide in HIV-associated non-Hodgkin lymphoma: pooled results from 3 phase 2 trials.

  2005cited by this paper
• Prognostic factors in HIV-related diffuse large-cell lymphoma: before versus after highly active antiretroviral therapy.

  2005influential reference
• A Prognostic Index for Systemic AIDS-Related Non-Hodgkin Lymphoma Treated in the Era of Highly Active Antiretroviral Therapy

  2005cited by this paper
• Outcome in patients with non-hodgkin lymphoma and with or without human immunodeficiency virus infection.

  2004cited by this paper
• High-dose therapy and autologous peripheral-blood stem-cell transplantation as salvage treatment for HIV-associated lymphoma in patients receiving highly active antiretroviral therapy.

  2003cited by this paper
• Lack of influence of human immunodeficiency virus infection status in the response to therapy and survival of adult patients with mature B-cell lymphoma or leukemia. Results of the PETHEMA-LAL3/97 study.

  2003cited by this paper
• Response to highly active antiretroviral therapy strongly predicts outcome in patients with AIDS-related lymphoma

  2003cited by this paper
• Highly effective treatment of acquired immunodeficiency syndrome-related lymphoma with dose-adjusted EPOCH: impact of antiretroviral therapy suspension and tumor biology.

  2003cited by this paper
• Favorable Impact of Virological Response to Highly Active Antiretroviral Therapy on Survival in Patients with AIDS-related Lymphoma

  2002cited by this paper
• Prognostic impact of highly active antiretroviral therapy in HIV-related Hodgkin's disease.

  2002cited by this paper
• E.S. Jaffe, N.L. Harris, H. Stein, J.W. Vardiman (eds). World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues

  2002cited by this paper
• Better response to chemotherapy and prolonged survival in AIDS-related lymphomas responding to highly active antiretroviral therapy

  2001cited by this paper
• Influence of highly active anti‐retroviral therapy on response to treatment and survival in patients with acquired immunodeficiency syndrome‐related non‐Hodgkin's lymphoma treated with cyclophosphamide, hydroxydoxorubicin, vincristine and prednisone

  2001cited by this paper
• Non-Hodgkin lymphoma in HIV-infected patients in the era of highly active antiretroviral therapy.

  2001cited by this paper
• Epidemiological, biological and clinical features of HIV-related lymphomas in the era of highly active antiretroviral therapy.

  2000cited by this paper
• Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group.

  1999cited by this paper
• International prognostic index is the best prognostic factor for survival in patients with AIDS-related non-Hodgkin's lymphoma treated with CHOP. A multivariate study of 46 patients.

  1998cited by this paper
• Low-dose compared with standard-dose m-BACOD chemotherapy for non-Hodgkin's lymphoma associated with human immunodeficiency virus infection. National Institute of Allergy and Infectious Diseases AIDS Clinical Trials Group.

  1997cited by this paper
• Clinical evaluation of 451 patients with HIV related non-Hodgkin's lymphoma: experience on the Italian cooperative group on AIDS and tumors (GICAT).

  1995cited by this paper
• Human immunodeficiency virus-related lymphoma treatment with intensive combination chemotherapy. French-Italian Cooperative Group.

  1993cited by this paper
• A predictive model for aggressive non-Hodgkin's lymphoma.

  1993cited by this paper
• 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults.

  1993cited by this paper
• Human immunodeficiency virus-related lymphoma treatment with intensive combination chemotherapy

  1993cited by this paper
• Conservatism of the approximation sigma (O-E)2-E in the logrank test for survival data or tumor incidence data.

  1973cited by this paper
• Regression Models and Life-Tables

  1972cited by this paper
• Report of the Committee on Hodgkin's Disease Staging Classification.

  1971cited by this paper
• Nonparametric Estimation from Incomplete Observations

  1958cited by this paper

• Features of human acquired immunodeficiency virus-associated non-Hodgkin's lymphoma

  2023cites this paper
• Two-Stage Approaches to Accounting for Patient Heterogeneity in Machine Learning Risk Prediction Models in Oncology.

  2021cites this paper
• Prognostic factors in HIV-positive patients with non-Hodgkin lymphoma: a Peruvian experience

  2018cites this paper
• Splenic and hepatic ultrasound and cytology in canine lymphoma: effects of findings on stage migration and assessment of prognosis.

  2016cites this paper
• Prognostic Factors in HIV-Associated Lymphoma

  2013cites this paper
• Large Cell Lymphoma: Correlation of HIV Status and Prognosis with Differentiation Profiles Assessed by Immunophenotyping

  2013cites this paper
• The characteristics of health Literacy of residents in hubei province

  2011cites this paper
• Head and Neck Manifestations in the Immunocompromised Host

  2010cites this paper
• Investigating caspases and other markers of apoptosis in ITP

  2010cites this paper
• A prognostic score for AIDS-related diffuse large B-cell lymphoma in Brazil

  2009cites this paper